来源:Gangtise投研
药网(YI)在2024年第三季度业绩电话会中,分析了宏观经济对行业的影响和数字化转型机遇,以及公司在运营效率、技术与数字化建设、供应链管理等方面的成果。公司指出,尽管宏观经济下消费者情绪疲软,但数字化转型是应对挑战的关键,公司已实施前沿数字技术提升运营能力。公司看好中国医疗保健市场,认为医疗反腐和人口老龄化将推动市场增长。在运营效率方面,公司连续三个季度实现运营利润,并有效控制运营费用。此外,公司持续投资技术,提升数字化能力,优化B2C零售业务和中药领域应用。供应链管理方面,公司通过创新和优化降低成本,提升效率。公司还分享了财务状况,包括总净收入、利润增长和各项费用占比变化。在Q&A环节,公司回答了关于欧佩克占比、毛利率改善、运营效率提升、供应链管理改进、数字能力进展和合作伙伴关系扩张计划等问题。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.